Sensitive ASX Announcement

Opthea Meets Primary Safety Objective in DME Phase 1b trial

Published: 26/07/18, 08:30am (AEST)3 pages
Opthea Limited
OPT:ASXHealthcare

Recent OPT Announcements

Price Sensitive only